Dated: Oct 04, 2018
Publication Name: British Journal of Anaesthesia
Citations : Lidocaine inhibits cytoskeletal remodelling and human breast cancer cell migration
The metastatic potential of breast cancer cells has been strongly associated with overexpression of the chemokine CXCL12 and the activity of its receptor CXCR4. Lidocaine, a local anaesthetic that can be used during breast cancer excision, inhibits the growth, invasion, and migration of cancer cells. We therefore investigated, in a breast cancer cell line, whether lidocaine can modulate CXCL12-induced responses.
Contributors: G.D'Agostino, A.Saporito, V.Cecchinato, Y.Silvestri, A.Borgeat, L.Anselmi, M.Uguccioni